Market revenue in 2023 | USD 3,209.8 million |
Market revenue in 2030 | USD 8,232.1 million |
Growth rate | 14.4% (CAGR from 2023 to 2030) |
Largest segment | Vitamins |
Fastest growing segment | Protiens & Amino Acids |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Vitamins, Botanicals, Minerals, Protiens & Amino Acids, Fibers & Specialty Carbohydrates, Omega Fatty Acids |
Key market players worldwide | Amway Malaysia Holdings, Abbott Laboratories, Bayer AG, Glanbia PLC, Pfizer Inc, Archer-Daniels Midland Co, Nu Skin Enterprises Inc Class A, GlaxoSmithKline, Herbalife Ltd, Natures Sunshine Products Inc, DuPont de Nemours Inc, Nestle SA, NOW Foods, RBK Nutraceuticals, Goodhealth |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dietary supplements market will help companies and investors design strategic landscapes.
Vitamins was the largest segment with a revenue share of 30.07% in 2023. Horizon Databook has segmented the ANZ dietary supplements market based on vitamins, botanicals, minerals, protiens & amino acids, fibers & specialty carbohydrates, omega fatty acids covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the ANZ dietary supplements market , including forecasts for subscribers. This country databook contains high-level insights into ANZ dietary supplements market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account